SLC5A2 and Hyperglycemia: Hyperglycemia leads to SGLT2 overexpression in human cardiomyocytes in vitro and in vivo, potentially resulting in systolic and diastolic dysfunction and, ultimately, heart failure, particularly in patients with DM6.